Blood Tests for Thyroid Disease: Complete Monitoring Guide
Whether you have hypothyroidism, hyperthyroidism, or Hashimoto's thyroiditis, managing thyroid disease requires more than a TSH check. This guide covers the full thyroid panel, what each result means for treatment, and how often each test should be repeated.
Upload your blood test PDF and get a free scored health breakdown.
Get My Score →The Complete Thyroid Test Panel
| Test | Normal Range | When to Order |
|---|---|---|
| TSH | 0.5–4.5 mIU/L | Initial screening; monitoring on treatment |
| Free T4 (FT4) | 0.8–1.8 ng/dL | Confirm thyroid function when TSH is abnormal |
| Free T3 (FT3) | 2.3–4.2 pg/mL | Assess T4-to-T3 conversion; persistent symptoms despite normal TSH/FT4 |
| Anti-TPO antibodies | Below 35 IU/mL | Confirm Hashimoto's or Graves' disease |
| Anti-TG antibodies | Below 20 IU/mL | Confirm Hashimoto's when anti-TPO is negative |
| TSI / TRAb | Negative | Confirm Graves' hyperthyroidism; monitor treatment |
| Thyroglobulin | Variable | Monitor thyroid cancer recurrence (post-thyroidectomy) |
Thyroid Test Hierarchy
Hypothyroidism: What to Monitor
On levothyroxine (synthetic T4) therapy, TSH is the primary monitoring tool — checked 6–8 weeks after any dose change, then annually once stable. The target TSH for most adults on levothyroxine is 0.5–2.5 mIU/L; in pregnancy the target tightens to 0.1–2.5 mIU/L in the first trimester. If symptoms persist despite TSH in range, checking Free T3 assesses whether T4-to-T3 conversion is adequate — some patients feel better with combination T4/T3 therapy, though this remains debated.
Hashimoto's Thyroiditis: The Autoimmune Pattern
Hashimoto's is the most common cause of hypothyroidism in iodine-sufficient countries like the US. It presents with elevated anti-TPO antibodies (and sometimes anti-TG) — often years before TSH becomes abnormal. In early Hashimoto's, thyroid function may fluctuate between hypo and hyperthyroid phases before settling into permanent hypothyroidism. Annual TSH monitoring is essential once antibodies are confirmed, even if thyroid function is currently normal.
Hyperthyroidism (Graves' Disease) Monitoring
Graves' disease is confirmed by TSI (thyroid-stimulating immunoglobulins) or TRAb (TSH receptor antibodies) — these autoantibodies mimic TSH and overstimulate the gland. During antithyroid drug treatment (methimazole or propylthiouracil), TSH and FT4 are monitored every 4–6 weeks initially, then every 3–6 months. TSI/TRAb levels are measured to predict whether remission is likely — falling antibody levels suggest the drugs can eventually be stopped; persistently high levels suggest radioiodine or surgery may be needed.
Symptoms That Suggest Hypothyroidism Despite Normal TSH
Monitoring After Thyroid Cancer Treatment
After thyroidectomy and radioiodine ablation for differentiated thyroid cancer, thyroglobulin (Tg) is the key surveillance marker — in the absence of thyroid tissue, any detectable thyroglobulin suggests recurrence. Anti-thyroglobulin antibodies (anti-TG) can interfere with Tg measurement and must always be checked alongside it. TSH is suppressed below 0.1 mIU/L with high-dose levothyroxine in high-risk patients to reduce stimulation of any residual cancer cells.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Reference ranges, supplement dosages, and nutritional information mentioned are general educational guidance from published research—not personalised recommendations. Do not use this content to self-diagnose or self-treat any condition. Always consult a qualified healthcare provider before making any changes to your health regimen, medications, or supplements.
See exactly where your results stand
Upload your blood test PDF and get a free A–F score across all 6 health domains in seconds.
Analyze My Blood Test →